In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community ...

She added that CSOs are crucial in pushing for government and private sector involvement. “They are the voice for the ...

Gene therapy may be a crucial tool to put HIV to sleep permanently, providing a lasting and durable treatment against the v ...

Drawing from 19 studies across sub-Saharan Africa and select global contexts, the review finds that RHIS remain largely ...

Oil prices jumped on Monday to their highest since January as the United States' weekend move to join Israel in attacking ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

In 2023, a clinical trial began in South Africa and the US to test the efficacy of a potential vaccine against HIV called VIR-1388. Like other vaccines, VIR-1388 would not be a cure for HIV but, if it ...